\-\ Texto\\:\\ \ \(0\)\
\-\ unremarkable\\,\\ no\\ neurologic\\ defecits\\.\ \(0\)\
\-\ the\\ patient\\ was\\ also\\ started\\ on\\ an\\ anti\\-seizure\\ medication\\ for\\ treatment\\ of\\ new\\-onset\\ seizure\\ activity\\.\\ \\ patient\\ was\\ to\\ have\\ a\\ follow\\-up\\ ct\\ or\\ mri\\ in\\ 6\\ months\\ to\\ confirm\\ stability\\.\ \(0\)\
\-\ right\\ frontosphenoid\\ temporooccipital\\ bone\\ deformity\\ with\\ mixed\\ density\\ and\\ a\\ large\\ component\\ showing\\ a\\ \\"ground\\ glass\\"\\ appearance\\.\ \(0\)\
\-\ fibrous\\ dysplasia\ \(50\)\
\-\ paget\\'s\\ disease\ \(1\)\
\-\ hyperparathyroidism\ \(35\)\
\-\ fibrous\\ dysplasia\ \(50\)\
\-\ neurofibromatosis\ \(24\)\
\-\ osteofibrous\\ dysplasia\ \(0\)\
\-\ nonossifying\\ fibroma\ \(10\)\
\-\ simple\\ bone\\ cyst\ \(7\)\
\-\ giant\\ cell\\ tumor\ \(18\)\
\-\ enchondromatosis\ \(9\)\
\-\ eosinophilic\\ granuloma\ \(17\)\
\-\ osteoblastoma\ \(15\)\
\-\ hemangioma\ \(165\)\
\-\ meningioma\ \(167\)\
\-\ patient\\ presented\\ to\\ the\\ ed\\ with\\ questionable\\ new\\ onset\\ seizure\\ activity\\.\\ \\ ct\\ to\\ rule\\ out\\ space\\ occupying\\ lesions\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ dysplasia\\:\\ 0\\.09824565184790403\ \(0\)\
\-\ frontosphenoid\\:\\ 0\\.08558755751423784\ \(0\)\
\-\ temporooccipital\\:\\ 0\\.08558755751423784\ \(0\)\
\-\ defecits\\:\\ 0\\.07492141878930474\ \(0\)\
\-\ osteofibrous\\:\\ 0\\.07492141878930474\ \(0\)\
\-\ seizure\\:\\ 0\\.07337021012724017\ \(0\)\
\-\ anti\\-seizure\\:\\ 0\\.06996194671390676\ \(0\)\
\-\ fibrous\\:\\ 0\\.06707235452926355\ \(0\)\
\-\ new\\-onset\\:\\ 0\\.06323236243662575\ \(0\)\
\-\ activity\\:\\ 0\\.06225333259769977\ \(0\)\
\-\ enchondromatosis\\:\\ 0\\.05996564169273048\ \(0\)\
\-\ nonossifying\\:\\ 0\\.054732665957461665\ \(0\)\
\-\ osteoblastoma\\:\\ 0\\.0543363359135757\ \(0\)\
\-\ occupying\\:\\ 0\\.05164088216019434\ \(0\)\
\-\ glass\\:\\ 0\\.04800308168018065\ \(0\)\
\-\ questionable\\:\\ 0\\.04685955706215751\ \(0\)\
\-\ stability\\:\\ 0\\.04633463258380532\ \(0\)\
\-\ fibroma\\:\\ 0\\.0461657807128163\ \(0\)\
\-\ paget\\:\\ 0\\.045999815340395905\ \(0\)\
\-\ neurofibromatosis\\:\\ 0\\.04583663943441162\ \(0\)\
\-\ ground\\:\\ 0\\.04567616077469113\ \(0\)\
\-\ eosinophilic\\:\\ 0\\.044479727372516875\ \(0\)\
\-\ hyperparathyroidism\\:\\ 0\\.04354160275417638\ \(0\)\
\-\ confirm\\:\\ 0\\.04222922626516422\ \(0\)\
\-\ medication\\:\\ 0\\.04179280502378299\ \(0\)\
\-\ bone\\:\\ 0\\.041231741387570284\ \(0\)\
\-\ simple\\:\\ 0\\.04087716735901365\ \(0\)\
\-\ granuloma\\:\\ 0\\.0407805622050994\ \(0\)\
\-\ giant\\:\\ 0\\.039951825807515357\ \(0\)\
\-\ showing\\:\\ 0\\.0381817136056323\ \(0\)\
\-\ component\\:\\ 0\\.03789187901194608\ \(0\)\
\-\ hemangioma\\:\\ 0\\.03707093349711051\ \(0\)\
\-\ started\\:\\ 0\\.03700555454389358\ \(0\)\
\-\ mixed\\:\\ 0\\.03643614942659739\ \(0\)\
\-\ deformity\\:\\ 0\\.035725436766177045\ \(0\)\
\-\ ed\\:\\ 0\\.035063220746501964\ \(0\)\
\-\ neurologic\\:\\ 0\\.03464557623112633\ \(0\)\
\-\ rule\\:\\ 0\\.03464557623112633\ \(0\)\
\-\ meningioma\\:\\ 0\\.03190377996558325\ \(0\)\
\-\ new\\:\\ 0\\.028910562881558816\ \(0\)\
\-\ unremarkable\\:\\ 0\\.02746666425904913\ \(0\)\
\-\ space\\:\\ 0\\.027442301039578974\ \(0\)\
\-\ out\\:\\ 0\\.027417998804451612\ \(0\)\
\-\ density\\:\\ 0\\.027297391814174357\ \(0\)\
\-\ follow\\-up\\:\\ 0\\.026990650402347008\ \(0\)\
\-\ onset\\:\\ 0\\.026188555591506308\ \(0\)\
\-\ patient\\:\\ 0\\.02494927954125402\ \(0\)\
\-\ 6\\:\\ 0\\.024777865644416253\ \(0\)\
\-\ appearance\\:\\ 0\\.02372724831781205\ \(0\)\
\-\ ct\\:\\ 0\\.023209779677515394\ \(0\)\
\-\ months\\:\\ 0\\.022659624220291913\ \(0\)\
\-\ presented\\:\\ 0\\.022615122670120474\ \(0\)\
\-\ cell\\:\\ 0\\.022410103995936757\ \(0\)\
\-\ cyst\\:\\ 0\\.022294865398311672\ \(0\)\
\-\ lesions\\:\\ 0\\.02220932530431017\ \(0\)\
\-\ \\`\\`\\:\\ 0\\.020389660559532202\ \(0\)\
\-\ \\'\\'\\:\\ 0\\.019997567980410125\ \(0\)\
\-\ tumor\\:\\ 0\\.019342061180687486\ \(0\)\
\-\ was\\:\\ 0\\.019189854800265763\ \(0\)\
\-\ mri\\:\\ 0\\.019060930630239028\ \(0\)\
\-\ \\'s\\:\\ 0\\.01829171474142762\ \(0\)\
\-\ large\\:\\ 0\\.018141188658554172\ \(0\)\
\-\ have\\:\\ 0\\.017965418236554287\ \(0\)\
\-\ treatment\\:\\ 0\\.01679239766602803\ \(0\)\
\-\ to\\:\\ 0\\.016585169259921796\ \(0\)\
\-\ also\\:\\ 0\\.016355530035632535\ \(0\)\
\-\ disease\\:\\ 0\\.01356055865257965\ \(0\)\
\-\ a\\:\\ 0\\.011551450538405863\ \(0\)\
\-\ an\\:\\ 0\\.011472474410531357\ \(0\)\
\-\ or\\:\\ 0\\.0097235218345991\ \(0\)\
\-\ right\\:\\ 0\\.008753705913693365\ \(0\)\
\-\ no\\:\\ 0\\.008353826705862155\ \(0\)\
\-\ for\\:\\ 0\\.007078719889735098\ \(0\)\
\-\ on\\:\\ 0\\.007028068081217748\ \(0\)\
\-\ in\\:\\ 0\\.0040912352440801445\ \(0\)\
\-\ the\\:\\ 0\\.002684452130167491\ \(0\)\
\-\ \\,\\:\\ 0\\.0026282530632746343\ \(0\)\
\-\ with\\:\\ 0\\.002271925749318247\ \(0\)\
\-\ \\.\\:\\ 0\\.002067934141592987\ \(0\)\
\-\ and\\:\\ 0\\.0017476602498273635\ \(0\)\
\-\ of\\:\\ 0\\.0011311048621163923\ \(0\)\
